<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T2" position="float">
 <label>Table 2</label>
 <caption>
  <p>Potential investigational therapies for nCOVID-19.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Drug class</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Drug</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Mechanism of action</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>Outcome</bold>
    </th>
    <th valign="top" align="left" rowspan="1" colspan="1">
     <bold>References</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Antiviral agents</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Remdesivir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibits viral RNA-dependent RNA polymerase (RdRp)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Showed promising 
     <italic>in vitro</italic> and clinical activity against coronavirus
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Brown et al., 
     <xref rid="B23" ref-type="bibr">2019</xref>; ClinicalTrials.gov, 
     <xref rid="B47" ref-type="bibr">2020e</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1">Favipiravir</td>
    <td rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1">Exhibited excellent activity in treating nCOVID-19 patients</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Xinhua News Agency, 
     <xref rid="B202" ref-type="bibr">2020</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1">Ribavirin</td>
    <td rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1">It showed effective antiviral activity against SARS-CoV, but can be detrimental for the patients with respiratory distress</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Chan et al., 
     <xref rid="B32" ref-type="bibr">2015</xref>; Martinez, 
     <xref rid="B124" ref-type="bibr">2020</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1">Umifenovir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibits entry of virus into the host cell</td>
    <td valign="top" align="left" rowspan="1" colspan="1">It can inhibit viral entry into the host cell</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Boriskin et al., 
     <xref rid="B21" ref-type="bibr">2008</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1">Lopinavir/ritonavir (LPV/r)</td>
    <td rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1">Combination of umifenovir and LPV/r showed better activity as compared to the sole use of LPV/r in nCOVID-19 treatment</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Deng et al., 
     <xref rid="B58" ref-type="bibr">2020</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Antimalarials</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Chloroquine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Prevents the viral fusion with the cell membrane of the host cell</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Findings from 
     <italic>in vitro</italic> studies are promising
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Vincent et al., 
     <xref rid="B182" ref-type="bibr">2005</xref>; Cortegiani et al., 
     <xref rid="B50" ref-type="bibr">2020</xref>; Wang et al., 
     <xref rid="B186" ref-type="bibr">2020b</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1">Hydroxychloroquine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Controls cytokine storm</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Showed excellent 
     <italic>in vitro</italic> activity as well as more potent and less likely to interact with other drugs as compared to chloroquine
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Yao et al., 
     <xref rid="B208" ref-type="bibr">2020</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Macrolide antibiotics</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Azithromycin</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Enhances the anti-SARS-CoV-2 effect of hydroxychloroquine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Combined use led to a reinforcement of hydroxychloroquine's efficacy in treating nCOVID-19 patients</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Gautret et al., 
     <xref rid="B71" ref-type="bibr">2020</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Glycopeptide antibiotics</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Teicoplanin and its derivatives</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibits cathepsin L and cathepsin B in host cells</td>
    <td valign="top" align="left" rowspan="1" colspan="1">They can selectively suppress the effects of cathepsins B and L in the host cell</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Wang et al., 
     <xref rid="B190" ref-type="bibr">2016</xref>; Zhou et al., 
     <xref rid="B219" ref-type="bibr">2016</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Antiparasitic agent</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Ivermectin</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Dissociates IMPα/β1 heterodimer</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Recent 
     <italic>in vivo</italic> study has been demonstrated that it can remarkably decrease the level of viral RNA
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Caly et al., 
     <xref rid="B25" ref-type="bibr">2020</xref>
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"/>
    <td valign="top" align="left" rowspan="1" colspan="1">Nitazoxanide</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Interferes with the host-regulated pathways linked with viral replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Exerted a potent 
     <italic>in vitro</italic> antiviral activity against SARS CoV-2
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">Wang et al., 
     <xref rid="B186" ref-type="bibr">2020b</xref>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
